{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:00:04Z","timestamp":1793606404532,"version":"4.5.0"},"reference-count":147,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research (ICMR), New Delhi, India","doi-asserted-by":"publisher","award":["2021-10799"],"award-info":[{"award-number":["2021-10799"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>The eye is an important and vital organ of the human body consisting of two segments - anterior\nand posterior segments and these segments are associated with many diseases. This review elaborates\nupon the various eye-related diseases with their medications and carriers used to deliver them.\nDelivery strategies include drugs encapsulated into liposomes, polymeric micelles of drugs, solid lipid\nnanoparticles, nanostructured lipid carriers, nano emulsions, and Nanosuspension used to improve penetrating\nproperties, bioavailability, and residence time of the drugs as examples available in the literature.\nWith regard to this, different forms of ocular drug delivery are classified and elaborated. Additionally,\nthe possibility of addressing the physical and chemical complexities of ocular diseases and how they\ncould be overcome with environmentally stable nanoformulations are briefly discussed. Enhanced drug\ndelivery efficiency with various novel pharmaceuticals along with enhanced uptake by different\nroutes\/modes of drug administration. Current advancements in drug carrier systems, i.e., nanocarriers,\nhave shown promise for improving the retention time, drug permeation and prolonging the duration of\nrelease of the drug in the ocular site. Bio-degradable polymers investigated for the preparation of\nnanocarriers for the entrapment of drugs and to enhance the efficacy through improved adherence of\ntissue in the eye, sustained release measures, enhanced bioavailability, lower toxicity, and targeted delivery\nis applicable. This review covers the introduction of various nanocarriers and polymers for ocular\ndrug delivery with the purpose of enhancing the absorption, retention and bioavailability of medications\nin the eye.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567201820666230504115446","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T04:49:08Z","timestamp":1683262148000},"page":"488-508","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A Mini-review on New Developments in Nanocarriers and Polymers for\nOphthalmic Drug Delivery Strategies"],"prefix":"10.2174","volume":"21","author":[{"given":"Yash","family":"Sharma","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Quality Assurance, ISF College Pharmacy, GT Road, Moga-142001, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1606-2241","authenticated-orcid":true,"given":"Preeti","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, ISF College Pharmacy, GT Road, Moga-142001, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8470-6622","authenticated-orcid":true,"given":"Balak Das","family":"Kurmi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, ISF College Pharmacy, GT Road, Moga-142001, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"108394","DOI":"10.1016\/j.exer.2020.108394","volume":"203","author":"Tkachev S.Y.","year":"2021","unstructured":"Tkachev S.Y.; Mitrin B.I.; Karnaukhov N.S.; Sadyrin E.V.; Voloshin M.V.; Maksimov A.Y.; Goncharova A.S.; Lukbanova E.A.; Zaikina E.V.; Volkova A.V.; Khodakova D.V.; Mindar M.V.; Yengibarian M.A.; Protasova T.P.; Kit S.O.; Ermakov A.M.; Chapek S.V.; Tkacheva M.S.; Visualization of different anatomical parts of the enucleated human eye using X-ray micro-CT imaging. Exp Eye Res 2021,203,108394","journal-title":"Exp Eye Res"},{"key":"ref=2","first-page":"192","volume":"2","author":"Allen L.V.","year":"1998","unstructured":"Allen L.V.; Jr Preservation, sterilization, and sterility testing of ophthalmic preparations. Int J Pharm Compd 1998,2(3),192-195","journal-title":"Int J Pharm Compd"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41467-022-28674-1","volume":"13","author":"Toral M.A.","year":"2022","unstructured":"Toral M.A.; Charlesworth C.T.; Ng B.; Chemudupati T.; Homma S.; Nakauchi H.; Bassuk A.G.; Porteus M.H.; Mahajan V.B.; Investi-gation of Cas9 antibodies in the human eye. Nat Commun 2022,13(1),1053","journal-title":"Nat Commun"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/IIO.0000000000000196","volume":"57","author":"Stryjewski T.P.","year":"2017","unstructured":"Stryjewski T.P.; Stefater J.A.; Eliott D.; Emerging applications for polymers in ophthalmology. Int Ophthalmol Clin 2017,57(4),137-149","journal-title":"Int Ophthalmol Clin"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/jbmr.5650111212","volume":"11","author":"Yasuoka T.","year":"1996","unstructured":"Yasuoka T.; Kawashima M.; Takahashi T.; Iwata A.; Oka N.; Tanaka K.; Changes in parathyroid hormone receptor binding affinity during egg laying: Implications for calcium homeostasis in chicken. J Bone Miner Res 1996,11(12),1913-1920","journal-title":"J Bone Miner Res"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ejpb.2004.03.005","volume":"58","author":"Baydoun L.","year":"2004","unstructured":"Baydoun L.; Furrer P.; Gurny R.; M\u00fcller-Goymann C.C.; New surface-active polymers for ophthalmic formulations: Evaluation of ocu-lar tolerance. Eur J Pharm Biopharm 2004,58(1),169-175","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/cxo.12391","volume":"99","author":"Wood J.M.","year":"2016","unstructured":"Wood J.M.; Black A.A.; Ocular disease and driving. Clin Exp Optom 2016,99(5),395-401","journal-title":"Clin Exp Optom"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.drudis.2013.10.001","volume":"19","author":"Almeida H.","year":"2014","unstructured":"Almeida H.; Amaral M.H.; Lob\u00e3o P.; Lobo J.M.S.; In situ gelling systems: A strategy to improve the bioavailability of ophthalmic phar-maceutical formulations. Drug Discov Today 2014,19(4),400-412","journal-title":"Drug Discov Today"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10237-021-01541-6","volume":"21","author":"Muench S.","year":"2022","unstructured":"Muench S.; Roellig M.; Balzani D.; A new method for the in vivo identification of degenerated material property ranges of the human eye: feasibility analysis based on synthetic data. Biomech Model Mechanobiol 2022,21(2),401-418","journal-title":"Biomech Model Mechanobiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1111\/jam.14290","volume":"127","author":"Singhvi M.S.","year":"2019","unstructured":"Singhvi M.S.; Zinjarde S.S.; Gokhale D.V.; Polylactic acid: Synthesis and biomedical applications. J Appl Microbiol 2019,127(6),1612-1626","journal-title":"J Appl Microbiol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2805402","DOI":"10.1155\/2022\/2805402","volume":"2022","author":"Rahman M.A.","year":"2022","unstructured":"Rahman M.A.; Rabbani M.; Maruf M.H.; Islam A.; Shihavuddin A.S.M.; Characterizing the aging process of the human eye: Tear evap-oration, fluid dynamics, blood flow, and metabolism-based comparative study. BioMed Res Int 2022,2022,2805402","journal-title":"BioMed Res Int"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1177\/0363546517716930","volume":"46","author":"Lopes T.J.A.","year":"2018","unstructured":"Lopes T.J.A.; Simic M.; Myer G.D.; Ford K.R.; Hewett T.E.; Pappas E.; The effects of injury prevention programs on the biomechanics of landing tasks: A systematic review with meta-analysis. Am J Sports Med 2018,46(6),1492-1499","journal-title":"Am J Sports Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/antiox10010089","volume":"10","author":"\u00c1lvarez-Barrios A.","year":"2021","unstructured":"\u00c1lvarez-Barrios A.; \u00c1lvarez L.; Garc\u00eda M.; Artime E.; Pereiro R.; Gonz\u00e1lez-Iglesias H.; Antioxidant defenses in the human eye: A focus on metallothioneins. Antioxidants 2021,10(1),89","journal-title":"Antioxidants"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/pharmaceutics14010090","volume":"14","author":"Bonilla L.","year":"2021","unstructured":"Bonilla L.; Espina M.; Severino P.; Cano A.; Ettcheto M.; Camins A.; Garc\u00eda M.L.; Souto E.B.; S\u00e1nchez-L\u00f3pez E.; Lipid nanoparticles for the posterior eye segment. Pharmaceutics 2021,14(1),90","journal-title":"Pharmaceutics"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"100773","DOI":"10.1016\/j.preteyeres.2019.100773","volume":"74","author":"Boote C.","year":"2020","unstructured":"Boote C.; Sigal I.A.; Grytz R.; Hua Y.; Nguyen T.D.; Girard M.J.A.; Scleral structure and biomechanics. Prog Retin Eye Res 2020,74,100773","journal-title":"Prog Retin Eye Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/APO.0000000000000426","author":"Ang J.L.","year":"2021","unstructured":"Ang J.L.; Collis S.; Dhillon B.; Cackett P.; The eye in forensic medicine. Asia-Pac J Ophthalmol 2021(5),486-494","journal-title":"Asia-Pac J Ophthalmol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1051\/medsci\/2020094","volume":"36","author":"Behar-Cohen F.","year":"2020","unstructured":"Behar-Cohen F.; Geliz\u00e9 E.; Jonet L.; Lassiaz P.; Anatomie de la r\u00e9tine. Med Sci (Paris) 2020,36(6-7),594-599","journal-title":"Med Sci (Paris)"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/0042-6989(77)90112-2","volume":"17","author":"Boll P.F.","year":"1977","unstructured":"Boll P.F.; On the anatomy and physiology of the retina. Vision Res 1977,17(11-12),1249-1265","journal-title":"Vision Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.clae.2021.02.009","volume":"44","author":"Downie L.E.","year":"2021","unstructured":"Downie L.E.; Bandlitz S.; Bergmanson J.P.G.; Craig J.P.; Dutta D.; Maldonado-Codina C.; Ngo W.; Siddireddy J.S.; Wolffsohn J.S.; BCLA CLEAR-Anatomy and physiology of the anterior eye. Cont Lens Anterior Eye 2021,44(2),132-156","journal-title":"Cont Lens Anterior Eye"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/15569527.2021.1910291","volume":"40","author":"Clippinger A.J.","year":"2021","unstructured":"Clippinger A.J.; Raabe H.A.; Allen D.G.; Choksi N.Y.; van der Zalm A.J.; Kleinstreuer N.C.; Barroso J.; Lowit A.B.; Human-relevant approaches to assess eye corrosion\/irritation potential of agrochemical formulations. Cutan Ocul Toxicol 2021,40(2),145-167","journal-title":"Cutan Ocul Toxicol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000099236","volume":"92","author":"Kaplan H.J.","year":"2007","unstructured":"Kaplan H.J.; Anatomy and function of the eye. Chem Immunol Allergy 2007,92,4-10","journal-title":"Chem Immunol Allergy"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1212\/CON.0000000000000771","volume":"25","author":"Bouffard M.A.","year":"2019","unstructured":"Bouffard M.A.; The pupil. Continuum 2019,25(5),1194-1214","journal-title":"Continuum"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.cveq.2017.07.006","volume":"33","author":"Gilger B.C.","year":"2017","unstructured":"Gilger B.C.; Advanced imaging of the equine eye. Vet Clin North Am Equine Pract 2017,33(3),607-626","journal-title":"Vet Clin North Am Equine Pract"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.neuropsychologia.2018.01.041","volume":"111","author":"Parr T.","year":"2018","unstructured":"Parr T.; Friston K.J.; Active inference and the anatomy of oculomotion. Neuropsychologia 2018,111,334-343","journal-title":"Neuropsychologia"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3390\/biomedicines10051125","volume":"10","author":"Fu Y.S.","year":"2022","unstructured":"Fu Y.S.; Chen P.R.; Yeh C.C.; Pan J.Y.; Kuo W.C.; Tseng K.W.; Human umbilical mesenchymal stem cell xenografts repair UV-induced photokeratitis in a rat model. Biomedicines 2022,10(5),1125","journal-title":"Biomedicines"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ajo.2021.09.015","volume":"235","author":"Chueh K.M.","year":"2022","unstructured":"Chueh K.M.; Hsieh Y.T.; Chen H.H.; Ma I.H.; Huang S.L.; Identification of sex and age from macular optical coherence tomography and feature analysis using deep learning. Am J Ophthalmol 2022,235,221-228","journal-title":"Am J Ophthalmol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"302001","DOI":"10.1088\/1361-6528\/abf3ee","volume":"32","author":"Regal S.","year":"2021","unstructured":"Regal S.; Troughton J.; Djenizian T.; Ramuz M.; Biomimetic models of the human eye, and their applications. Nanotechnology 2021,32(30),302001","journal-title":"Nanotechnology"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/ca.23766","volume":"34","author":"Tubbs R.S.","year":"2021","unstructured":"Tubbs R.S.; Anatomy, the eye of medicine. Clin Anat 2021,34(6),821","journal-title":"Clin Anat"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/ar.24043","volume":"303","author":"Franz-Odendaal T.A.","year":"2020","unstructured":"Franz-Odendaal T.A.; Skeletons of the eye: An evolutionary and developmental perspective. Anat Rec 2020,303(1),100-109","journal-title":"Anat Rec"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.jcrs.2018.07.017","volume":"44","author":"Sugiura T.","year":"2018","unstructured":"Sugiura T.; Kaji Y.; Tanaka Y.; Anatomy of the ciliary sulcus and the optimum site of needle passage for intraocular lens suture fixation in the living eye. J Cataract Refract Surg 2018,44(10),1247-1253","journal-title":"J Cataract Refract Surg"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/s41433-021-01593-z","volume":"36","author":"Ugradar S.","year":"2022","unstructured":"Ugradar S.; Kang J.; Kossler A.L.; Zimmerman E.; Braun J.; Harrison A.R.; Bose S.; Cockerham K.; Douglas R.S.; Teprotumumab for the treatment of chronic thyroid eye disease. Eye 2022,36(8),1553-1559","journal-title":"Eye"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ophtha.2021.10.017","volume":"129","author":"Douglas R.S.","year":"2022","unstructured":"Douglas R.S.; Kahaly G.J.; Ugradar S.; Elflein H.; Ponto K.A.; Fowler B.T.; Dailey R.; Harris G.J.; Schiffman J.; Tang R.; Wester S.; Jain A.P.; Marcocci C.; Marin\u00f2 M.; Antonelli A.; Eckstein A.; F\u00fchrer-Sakel D.; Salvi M.; Sile S.; Francis-Sedlak M.; Holt R.J.; Smith T.J.; Teprotumumab efficacy, safety, and durability in longer-duration thyroid eye disease and re-treatment. Ophthalmology 2022,129(4),438-449","journal-title":"Ophthalmology"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ajo.2019.07.021","volume":"208","author":"Patel A.","year":"2019","unstructured":"Patel A.; Yang H.; Douglas R.S.; A new era in the treatment of thyroid eye disease. Am J Ophthalmol 2019,208,281-288","journal-title":"Am J Ophthalmol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.survophthal.2019.10.004","volume":"65","author":"Bjordal O.","year":"2020","unstructured":"Bjordal O.; Norheim K.B.; R\u00f8dahl E.; Jonsson R.; Omdal R.; Primary Sj\u00f6gren\u2019s syndrome and the eye. Surv Ophthalmol 2020,65(2),119-132","journal-title":"Surv Ophthalmol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/jcm11020399","volume":"11","author":"Skarlis C.","year":"2022","unstructured":"Skarlis C.; Raftopoulou S.; Mavragani C.P.; Sjogren\u2019s syndrome: Recent updates. J Clin Med 2022,11(2),399","journal-title":"J Clin Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"114017","DOI":"10.1016\/j.envres.2022.114017","volume":"214","author":"Chen Y.","year":"2022","unstructured":"Chen Y.; He Y.S.; Feng Y.T.; Wu Z.D.; Wang J.; Yin K.J.; Huang J.X.; Pan H.F.; The effect of air pollution exposure on risk of outpa-tient visits for Sjogren\u2019s syndrome: A time-series study. Environ Res 2022,214(Pt 3),114017","journal-title":"Environ Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/ICO.0000000000001865","volume":"38","author":"Akpek E.K.","year":"2019","unstructured":"Akpek E.K.; Bunya V.Y.; Saldanha I.J.; Sj\u00f6gren\u2019s syndrome: More than just dry eye. Cornea 2019,38(5),658-661","journal-title":"Cornea"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"e201700377","DOI":"10.1002\/jbio.201700377","volume":"11","author":"Ivanov I.V.","year":"2018","unstructured":"Ivanov I.V.; Mappes T.; Schaupp P.; Lappe C.; Wahl S.; Ultraviolet radiation oxidative stress affects eye health. J Biophotonics 2018,11(7),e201700377","journal-title":"J Biophotonics"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"12661","DOI":"10.1080\/21655979.2022.2075306","volume":"13","author":"Tian M.","year":"2022","unstructured":"Tian M.; Yang J.; Yan X.; Cao Y.; Liu Y.; Lei Y.; Lv H.; Knockdown of lncRNA TUG1 alleviates diabetic retinal vascular dysfunction through regulating miR-524-5p\/FGFR2. Bioengineered 2022,13(5),12661-12672","journal-title":"Bioengineered"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"277","DOI":"10.7150\/thno.63441","volume":"12","author":"Suo L.","year":"2022","unstructured":"Suo L.; Liu C.; Zhang Q.Y.; Yao M.D.; Ma Y.; Yao J.; Jiang Q.; Yan B.; METTL3-mediated N6 -methyladenosine modification gov-erns pericyte dysfunction during diabetes-induced retinal vascular complication. Theranostics 2022,12(1),277-289","journal-title":"Theranostics"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"011905","DOI":"10.1063\/5.0130259","volume":"35","author":"Abazari M.A.","year":"2023","unstructured":"Abazari M.A.; Soltani M.; Kashkooli F.M.; Targeted nano-sized drug delivery to heterogeneous solid tumor microvasculatures: Implica-tions for immunoliposomes exhibiting bystander killing effect. Phys Fluids 2023,35(1),011905","journal-title":"Phys Fluids"},{"key":"ref=42","first-page":"51375","volume":"90","author":"Birsner A.E.","year":"2014","unstructured":"Birsner A.E.; Benny O.; D\u2019Amato R.J.; The corneal micropocket assay: A model of angiogenesis in the mouse eye. J Vis Exp 2014,90,51375","journal-title":"J Vis Exp"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/ceo.14027","volume":"50","author":"Keller K.E.","year":"2022","unstructured":"Keller K.E.; Peters D.M.; Pathogenesis of glaucoma: Extracellular matrix dysfunction in the trabecular meshwork\u2010A review. Clin Exp Ophthalmol 2022,50(2),163-182","journal-title":"Clin Exp Ophthalmol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"100916","DOI":"10.1016\/j.preteyeres.2020.100916","volume":"83","author":"Baudouin C.","year":"2021","unstructured":"Baudouin C.; Kolko M.; Melik-Parsadaniantz S.; Messmer E.M.; Inflammation in Glaucoma: From the back to the front of the eye, and beyond. Prog Retin Eye Res 2021,83,100916","journal-title":"Prog Retin Eye Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.maturitas.2022.05.002","volume":"163","author":"Lee S.S.Y.","year":"2022","unstructured":"Lee S.S.Y.; Mackey D.A.; Glaucoma-risk factors and current challenges in the diagnosis of a leading cause of visual impairment. Maturitas 2022,163,15-22","journal-title":"Maturitas"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/02713683.2022.2039204","volume":"48","author":"Powell S.","year":"2023","unstructured":"Powell S.; Irnaten M.; O\u2019Brien C.; Glaucoma-\u2018A stiff eye in a stiff body\u2019. Curr Eye Res 2023,48(2),152-160","journal-title":"Curr Eye Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/OPTH.S229815","volume":"14","author":"Mylla Boso A.L.","year":"2020","unstructured":"Mylla Boso A.L.; Gasperi E.; Fernandes L.; Costa V.P.; Alves M.; Impact of ocular surface disease treatment in patients with glaucoma. Clin Ophthalmol 2020,14,103-111","journal-title":"Clin Ophthalmol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/08164622.2021.1962210","volume":"105","author":"Lee Y.","year":"2022","unstructured":"Lee Y.; Kim M.; Galor A.; Beyond dry eye: How co-morbidities influence disease phenotype in dry eye disease. Clin Exp Optom 2022,105(2),177-185","journal-title":"Clin Exp Optom"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/pharmaceutics13020207","volume":"13","author":"Agarwal P.","year":"2021","unstructured":"Agarwal P.; Craig J.P.; Rupenthal I.D.; Formulation considerations for the management of dry eye disease. Pharmaceutics 2021,13(2),207","journal-title":"Pharmaceutics"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1001\/jamaophthalmol.2022.1818","volume":"140","author":"Christen W.G.","year":"2022","unstructured":"Christen W.G.; Cook N.R.; Manson J.E.; Buring J.E.; Lee I.M.; Bubes V.; Friedenberg G.; Dushkes R.; Smith D.; Schaumberg D.A.; Manson J.A.M.; Buring J.E.; Cook N.R.; Lee I-M.; Christen W.G.; Bassuk S.S.; Mora S.; Gibson H.; Gordon D.; Copeland T.; D\u2019Agostino D.; Friedenberg G.; Ridge C.; Bubes V.; Giovannucci E.L.; Willett W.C.; Baron J.; Holick M.; Hollis B.; Albert C.M.; Gold D.; LeBoff M.; Okereke O.; Pradhan A.; Sesso H.; Chen W.; Chandler P.; Gaziano J.M.; Demler O.; Rexrode K.; Costenbader K.; Forman J.; Alexander E.; Friedman S.; Katz J.; Zhang S.; Lin J.; Walter J.; Duszlak J.; Kalan K.; MacFadyen J.; Gomelskaya N.; Bates D.; Sarkissian A.; Breen M.; Andrade Y.; Vinayagamoorthy M.; Li C.; Kim E.; Giulianini F.; Kotler G.; Van Denburgh M.; Dushkes R.; Liu Y.; Pereira E.; Johnson L.F.; Menjin G.; Liu L.; Girard L.; Zeller S.; Riches N.; Hasson K.; Bhang E.; Revilla M.; McCarthy E.; Moran A.; Halse K.; Arsenault L.; Quinn P.; Grimes S.; Fitchorov I.; Schwerin K.; Curry S.; Murray A.; Zhang A.; Walron-Williams D.; Weinberg A.; Pfeffer C.; Haubourg M.; Nguyen V.; Ouellette H.; Rodriguez R.; Montgomery T.; Morse K.; Guzman V.; Perry M.; Weekes S.; Smith D.; Clar A.; Curran S.; Fonge Y.; Hibbert D.; Paine L.; Royce K.; Splaine C.; McMahon J.; Eldridge D.; Hand L.; Inandan K.; RieuWerden, M.; Samuelson, H.; Hrbek, A.; Mele, M.; Bowes, E.; Ryan, M.A.; Camargo, C.; Danik, J.; Thadhani, R.; Wang, T.; Shah, R.C.; Albert, M.A. Efficacy of Marine \u03c9-3 fatty acid supplementation vs. placebo in reducing incidence of dry eye disease in healthy US adults. JAMA Ophthalmol 2022,140(7),707-714","journal-title":"JAMA Ophthalmol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/NHH.0000000000000652","volume":"36","author":"Rouen P.A.","year":"2018","unstructured":"Rouen P.A.; White M.L.; Dry eye disease. Home Healthc Now 2018,36(2),74-83","journal-title":"Home Healthc Now"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2147\/OPTH.S5555","volume":"3","author":"Gayton J.","year":"2009","unstructured":"Gayton J.; Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol 2009,3,405-412","journal-title":"Clin Ophthalmol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.1016\/S0039-6257(00)00202-2","volume":"45","author":"Brewitt H.","year":"2001","unstructured":"Brewitt H.; Sistani F.; Dry eye disease: The scale of the problem. Surv Ophthalmol 2001,45(Suppl. 2),S199-S202","journal-title":"Surv Ophthalmol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"24434","DOI":"10.1038\/s41598-021-03887-4","volume":"11","author":"Neti N.","year":"2021","unstructured":"Neti N.; Prabhasawat P.; Chirapapaisan C.; Ngowyutagon P.; Provocation of dry eye disease symptoms during COVID-19 lockdown. Sci Rep 2021,11(1),24434","journal-title":"Sci Rep"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/opo.12888","volume":"41","author":"Papas E.B.","year":"2021","unstructured":"Papas E.B.; The global prevalence of dry eye disease: A Bayesian view. Ophthalmic Physiol Opt 2021,41(6),1254-1266","journal-title":"Ophthalmic Physiol Opt"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1089\/jwh.2018.7041","volume":"28","author":"Matossian C.","year":"2019","unstructured":"Matossian C.; McDonald M.; Donaldson K.E.; Nichols K.K.; MacIver S.; Gupta P.K.; Dry eye disease: Consideration for women\u2019s health. J Womens Health 2019,28(4),502-514","journal-title":"J Womens Health"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1586\/eop.09.70","volume":"5","author":"Shah S.S.","year":"2010","unstructured":"Shah S.S.; Denham L.V.; Elison J.R.; Bhattacharjee P.S.; Clement C.; Huq T.; Hill J.M.; Drug delivery to the posterior segment of the eye for pharmacologic therapy. Expert Rev Ophthalmol 2010,5(1),75-93","journal-title":"Expert Rev Ophthalmol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.2147\/OPTH.S165722","volume":"12","author":"Shah T.J.","year":"2018","unstructured":"Shah T.J.; Conway M.D.; Peyman G.A.; Intracameral dexamethasone injection in the treatment of cataract surgery induced inflammation: design, development, and place in therapy. Clin Ophthalmol 2018,12,2223-2235","journal-title":"Clin Ophthalmol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1517\/17425247.1.1.99","volume":"1","author":"Raghava S.","year":"2004","unstructured":"Raghava S.; Hammond M.; Kompella U.B.; Periocular routes for retinal drug delivery. Expert Opin Drug Deliv 2004,1(1),99-114","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"112008","DOI":"10.1016\/j.biopha.2021.112008","volume":"142","author":"El-Feky Y.A.","year":"2021","unstructured":"El-Feky Y.A.; Fares A.R.; Zayed G.; El-Telbany R.F.A.; Ahmed K.A.; El-Telbany D.F.A.; Repurposing of nifedipine loaded in situ ophthalmic gel as a novel approach for glaucoma treatment. Biomed Pharmacother 2021,142,112008","journal-title":"Biomed Pharmacother"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.2147\/DDDT.S309648","volume":"15","author":"Ma B.","year":"2021","unstructured":"Ma B.; Pang L.; Huang P.; Bai J.; Zhang Z.; Wu H.; Cai M.; Yang J.; Xu Y.; Yin X.; Qu C.; Ni J.; Topical delivery of levocarnitine to the cornea and anterior eye by thermosensitive in situ gel for dry eye disease. Drug Des Devel Ther 2021,15,2357-2373","journal-title":"Drug Des Devel Ther"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1177\/09603271211017314","volume":"40","author":"Samimi M.S.","year":"2021","unstructured":"Samimi M.S.; Mahboobian M.M.; Mohammadi M.; Ocular toxicity assessment of nanoemulsion in situ gel formulation of fluconazole. Hum Exp Toxicol 2021,40(12),2039-2047","journal-title":"Hum Exp Toxicol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/pharmaceutics13030360","volume":"13","author":"Eldesouky L.M.","year":"2021","unstructured":"Eldesouky L.M.; El-Moslemany R.M.; Ramadan A.A.; Morsi M.H.; Khalafallah N.M.; Cyclosporine lipid nanocapsules as ther-moresponsive gel for dry eye management: Promising corneal mucoadhesion, biodistribution and preclinical efficacy in rabbits. Pharmaceutics 2021,13(3),360","journal-title":"Pharmaceutics"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/17425247.2020.1735348","volume":"17","author":"Ge Y.","year":"2020","unstructured":"Ge Y.; Zhang A.; Sun R.; Xu J.; Yin T.; He H.; Gou J.; Kong J.; Zhang Y.; Tang X.; Penetratin-modified lutein nanoemulsion in situ gel for the treatment of age-related macular degeneration. Expert Opin Drug Deliv 2020,17(4),603-619","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijbiomac.2018.01.123","volume":"110","author":"Paulsamy M.","year":"2018","unstructured":"Paulsamy M.; Ponnusamy C.; Palanisami M.; Nackeeran G.; Paramasivam S.; Sugumaran A.; Kandasamy R.; Natesan S.; Palanichamy R.; Nepafenac loaded silica nanoparticles dispersed in situ gel systems: Development and characterization. Int J Biol Macromol 2018,110,336-345","journal-title":"Int J Biol Macromol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/pharmaceutics12060572","volume":"12","author":"Youssef A.","year":"2020","unstructured":"Youssef A.; Dudhipala N.; Majumdar S.; Ciprofloxacin loaded nanostructured lipid carriers incorporated into in situ gels to improve management of bacterial endophthalmitis. Pharmaceutics 2020,12(6),572","journal-title":"Pharmaceutics"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"12010","DOI":"10.1038\/s41598-020-68722-8","volume":"10","author":"Churchward C.P.","year":"2020","unstructured":"Churchward C.P.; Al-Kinani A.A.; Abdelkader H.; Swinden J.; Siwoku O.; Varnakulasingam T.; Alany R.G.; Snyder L.A.S.; Mono-caprin eye drop formulation to combat antibiotic resistant gonococcal blindness. Sci Rep 2020,10(1),12010","journal-title":"Sci Rep"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"861904","DOI":"10.1155\/2014\/861904","volume":"2014","author":"Baranowski P.","year":"2014","unstructured":"Baranowski P.; Karolewicz B.; Gajda M.; Pluta J.; Ophthalmic drug dosage forms: Characterisation and research methods. ScientificWorldJournal 2014,2014,861904","journal-title":"ScientificWorldJournal"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2174\/2589977512666200929111952","volume":"13","author":"Pawar P.","year":"2021","unstructured":"Pawar P.; Duduskar A.; Waydande S.; Design and evaluation of eudragit rs-100 based itraconazole nanosuspension for ophthalmic appli-cation. Curr Drug Res Rev 2021,13(1),36-48","journal-title":"Curr Drug Res Rev"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2147\/OPTH.S229879","volume":"14","author":"Ceriotti L.","year":"2020","unstructured":"Ceriotti L.; Balzaretti S.; Barone S.; Meloni M.; Eye irritation potential of microglycine and microglycine-containing ointments: An in vitro study on reconstructed human corneal epithelium. Clin Ophthalmol 2020,14,257-267","journal-title":"Clin Ophthalmol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/pharmaceutics10010010","volume":"10","author":"Dubald M.","year":"2018","unstructured":"Dubald M.; Bourgeois S.; Andrieu V.; Fessi H.; Ophthalmic drug delivery systems for antibiotherapy\u2014a review. Pharmaceutics 2018,10(1),10","journal-title":"Pharmaceutics"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1097\/j.jcrs.0000000000000267","volume":"46","author":"Chang D.F.","year":"2020","unstructured":"Chang D.F.; Thiel C.L.; Ophthalmic Instrument C.; Survey of cataract surgeons\u2019 and nurses\u2019 attitudes toward operating room waste. J Cataract Refract Surg 2020,46(7),933-940","journal-title":"J Cataract Refract Surg"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s11095-018-2513-3","volume":"35","author":"Bao Q.","year":"2018","unstructured":"Bao Q.; Burgess D.J.; Perspectives on physicochemical and in vitro profiling of ophthalmic ointments. Pharm Res 2018,35(12),234","journal-title":"Pharm Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.ijbiomac.2019.10.193","volume":"152","author":"Noreen S.","year":"2020","unstructured":"Noreen S.; Ghumman S.A.; Batool F.; Ijaz B.; Basharat M.; Noureen S.; Kausar T.; Iqbal S.; Terminalia arjuna gum\/alginate in situ gel system with prolonged retention time for ophthalmic drug delivery. Int J Biol Macromol 2020,152,1056-1067","journal-title":"Int J Biol Macromol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"121379","DOI":"10.1016\/j.ijpharm.2021.121379","volume":"612","author":"Esteruelas G.","year":"2022","unstructured":"Esteruelas G.; Halbaut L.; Garc\u00eda-Torra V.; Espina M.; Cano A.; Ettcheto M.; Camins A.; Souto E.B.; Luisa Garc\u00eda M.; S\u00e1nchez-L\u00f3pez E.; Development and optimization of Riluzole-loaded biodegradable nanoparticles incorporated in a mucoadhesive in situ gel for the posterior eye segment. Int J Pharm 2022,612,121379","journal-title":"Int J Pharm"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3109\/10837450.2014.910807","volume":"20","author":"Khan N.","year":"2015","unstructured":"Khan N.; Aqil M.; Imam S.S.; Ali A.; Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug deliv-ery: In vitro and ex vivo characterization. Pharm Dev Technol 2015,20(6),662-669","journal-title":"Pharm Dev Technol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ijpharm.2016.02.027","volume":"502","author":"Al Khateb K.","year":"2016","unstructured":"Al Khateb K.; Ozhmukhametova E.K.; Mussin M.N.; Seilkhanov S.K.; Rakhypbekov T.K.; Lau W.M.; Khutoryanskiy V.V.; In situ gelling systems based on Pluronic F127\/Pluronic F68 formulations for ocular drug delivery. Int J Pharm 2016,502(1-2),70-79","journal-title":"Int J Pharm"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ijpharm.2006.01.029","volume":"315","author":"Liu Z.","year":"2006","unstructured":"Liu Z.; Li J.; Nie S.; Liu H.; Ding P.; Pan W.; Study of an alginate\/HPMC-based in situ gelling ophthalmic delivery system for gatifloxa-cin. Int J Pharm 2006,315(1-2),12-17","journal-title":"Int J Pharm"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2021035767","volume":"38","author":"Momin M.M.","year":"2021","unstructured":"Momin M.M.; Afreen S.D.; Nanoformulations and highlights of clinical studies for ocular drug delivery systems: An overview. Crit Rev Ther Drug Carrier Syst 2021,38(4),79-107","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.3390\/ma14154290","volume":"14","author":"Koutsoviti M.","year":"2021","unstructured":"Koutsoviti M.; Siamidi A.; Pavlou P.; Vlachou M.; Recent advances in the excipients used for modified ocular drug delivery. Materials 2021,14(15),4290","journal-title":"Materials"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1039\/D1BM01537K","volume":"10","author":"Garcia C.R.","year":"2022","unstructured":"Garcia C.R.; Malik M.H.; Biswas S.; Tam V.H.; Rumbaugh K.P.; Li W.; Liu X.; Nanoemulsion delivery systems for enhanced efficacy of antimicrobials and essential oils. Biomater Sci 2022,10(3),633-653","journal-title":"Biomater Sci"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1167\/tvst.11.5.16","volume":"11","author":"Fardous J.","year":"2022","unstructured":"Fardous J.; Inoue Y.; Yoshida K.; Ono F.; Higuchi A.; Ijima H.; Delivery of hydrophobic drugs to the posterior ocular region by gel-in-water nanoemulsion. Transl Vis Sci Technol 2022,11(5),16","journal-title":"Transl Vis Sci Technol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"113973","DOI":"10.1016\/j.addr.2021.113973","volume":"178","author":"Kasza K.","year":"2021","unstructured":"Kasza K.; Gurnani P.; Hardie K.R.; C\u00e1mara M.; Alexander C.; Challenges and solutions in polymer drug delivery for bacterial biofilm treatment: A tissue-by-tissue account. Adv Drug Deliv Rev 2021,178,113973","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0939-6411(03)00159-0","volume":"57","author":"Yasueda S.","year":"2004","unstructured":"Yasueda S.; Inada K.; Matsuhisa K.; Terayama H.; Ohtori A.; Evaluation of ophthalmic suspensions using surface tension. Eur J Pharm Biopharm 2004,57(2),377-382","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/17469899.2022.2114456","volume":"17","author":"Thomas J.","year":"2022","unstructured":"Thomas J.; Kim L.; Albini T.; Yeh S.; Triamcinolone acetonide injectable suspension for suprachoroidal use in the treatment of macular edema associated with uveitis. Expert Rev Ophthalmol 2022,17(3),165-173","journal-title":"Expert Rev Ophthalmol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08982104.2022.2087083","author":"Gonz\u00e1lez Cela Casamayor M.A.","year":"2022","unstructured":"Gonz\u00e1lez Cela Casamayor M.A.; L\u00f3pez Cano J.J.; Andr\u00e9s Guerrero V.; Herrero Vanrell R.; Ben\u00edtez del Castillo J.M.; Molina Mart\u00ednez I.T.; A novel osmoprotective liposomal formulation from synthetic phospholipids to reduce in vitro hyperosmolar stress in dry eye treat-ments. J Liposome Res 2022,1-12","journal-title":"J Liposome Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jconrel.2007.07.009","volume":"122","author":"Nanjawade B.K.","year":"2007","unstructured":"Nanjawade B.K.; Manvi F.V.; Manjappa A.S.; RETRACTED: In situ-forming hydrogels for sustained ophthalmic drug delivery. J Control Release 2007,122(2),119-134","journal-title":"J Control Release"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2003.09.016","volume":"269","author":"Kaur I.P.","year":"2004","unstructured":"Kaur I.P.; Garg A.; Singla A.K.; Aggarwal D.; Vesicular systems in ocular drug delivery: An overview. Int J Pharm 2004,269(1),1-14","journal-title":"Int J Pharm"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.drudis.2007.10.021","volume":"13","author":"Sahoo S.","year":"2008","unstructured":"Sahoo S.; Dilnawaz F.; Krishnakumar S.; Nanotechnology in ocular drug delivery. Drug Discov Today 2008,13(3-4),144-151","journal-title":"Drug Discov Today"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","volume":"57","author":"del Amo E.M.","year":"2017","unstructured":"del Amo E.M.; Rimpel\u00e4 A.K.; Heikkinen E.; Kari O.K.; Ramsay E.; Lajunen T.; Schmitt M.; Pelkonen L.; Bhattacharya M.; Richard-son D.; Subrizi A.; Turunen T.; Reinisalo M.; Itkonen J.; Toropainen E.; Casteleijn M.; Kidron H.; Antopolsky M.; Vellonen K.S.; Ruponen M.; Urtti A.; Pharmacokinetic aspects of retinal drug delivery. Prog Retin Eye Res 2017,57,134-185","journal-title":"Prog Retin Eye Res"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/08982104.2016.1224899","volume":"27","author":"Fu T.","year":"2017","unstructured":"Fu T.; Yi J.; Lv S.; Zhang B.; Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy. J Liposome Res 2017,27(3),228-233","journal-title":"J Liposome Res"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"121725","DOI":"10.1016\/j.ijpharm.2022.121725","volume":"620","author":"Tavakoli S.","year":"2022","unstructured":"Tavakoli S.; Puranen J.; Bahrpeyma S.; Lautala V.E.; Karumo S.; Lajunen T.; del Amo E.M.; Ruponen M.; Urtti A.; Liposomal sunitinib for ocular drug delivery: A potential treatment for choroidal neovascularization. Int J Pharm 2022,620,121725","journal-title":"Int J Pharm"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.3390\/pharmaceutics13101698","volume":"13","author":"L\u00f3pez-Machado A.","year":"2021","unstructured":"L\u00f3pez-Machado A.; D\u00edaz-Garrido N.; Cano A.; Espina M.; Badia J.; Baldom\u00e0 L.; Calpena A.C.; Souto E.B.; Garc\u00eda M.L.; S\u00e1nchez-L\u00f3pez E.; Development of lactoferrin-loaded liposomes for the management of dry eye disease and ocular inflammation. Pharmaceutics 2021,13(10),1698","journal-title":"Pharmaceutics"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"121455","DOI":"10.1016\/j.ijpharm.2022.121455","volume":"615","author":"Peito S.","year":"2022","unstructured":"Peito S.; Peixoto D.; Ferreira-Faria I.; Margarida Martins A.; Margarida Ribeiro H.; Veiga F.; Marto J.; Cl\u00e1udia Paiva-Santos A.; Nano- and microparticle-stabilized Pickering emulsions designed for topical therapeutics and cosmetic applications. Int J Pharm 2022,615,121455","journal-title":"Int J Pharm"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.xphs.2021.12.016","volume":"111","author":"Hassan H.A.F.M.","year":"2022","unstructured":"Hassan H.A.F.M.; Ali A.I.; ElDesawy E.M.; ElShafeey A.H.; Pharmacokinetic and pharmacodynamic evaluation of gemifloxacin chi-tosan nanoparticles as an antibacterial ocular dosage form. J Pharm Sci 2022,111(5),1497-1508","journal-title":"J Pharm Sci"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"2007102","DOI":"10.1002\/smll.202007102","volume":"17","author":"Somasundar A.","year":"2021","unstructured":"Somasundar A.; Sen A.; Chemically propelled nano and micromotors in the body: Quo Vadis? Small 2021,17(5),2007102","journal-title":"Small"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/02652048.2020.1851787","volume":"38","author":"Srivastava A.","year":"2021","unstructured":"Srivastava A.; Verma A.; Saraf S.; Jain A.; Tiwari A.; Panda P.K.; Jain S.K.; Mucoadhesive gastroretentive microparticulate system for programmed delivery of famotidine and clarithromycin. J Microencapsul 2021,38(3),151-163","journal-title":"J Microencapsul"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.drudis.2019.05.037","volume":"24","author":"Chang D.","year":"2019","unstructured":"Chang D.; Park K.; Famili A.; Hydrogels for sustained delivery of biologics to the back of the eye. Drug Discov Today 2019,24(8),1470-1482","journal-title":"Drug Discov Today"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejpb.2016.10.009","volume":"110","author":"S\u00e1nchez-L\u00f3pez E.","year":"2017","unstructured":"S\u00e1nchez-L\u00f3pez E.; Espina M.; Doktorovova S.; Souto E.B.; Garc\u00eda M.L.; Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part I - Barriers and determining factors in ocular delivery. Eur J Pharm Biopharm 2017,110,70-75","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jconrel.2020.07.031","volume":"326","author":"Ilochonwu B.C.","year":"2020","unstructured":"Ilochonwu B.C.; Urtti A.; Hennink W.E.; Vermonden T.; Intravitreal hydrogels for sustained release of therapeutic proteins. J Control Release 2020,326,419-441","journal-title":"J Control Release"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"112212","DOI":"10.1016\/j.msec.2021.112212","volume":"127","author":"Fang G.","year":"2021","unstructured":"Fang G.; Yang X.; Wang Q.; Zhang A.; Tang B.; Hydrogels-based ophthalmic drug delivery systems for treatment of ocular diseases. Mater Sci Eng C 2021,127,112212","journal-title":"Mater Sci Eng C"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3109\/03639045.2012.736515","volume":"39","author":"Achouri D.","year":"2013","unstructured":"Achouri D.; Alhanout K.; Piccerelle P.; Andrieu V.; Recent advances in ocular drug delivery. Drug Dev Ind Pharm 2013,39(11),1599-1617","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.msec.2019.03.060","volume":"100","author":"Ahmad I.","year":"2019","unstructured":"Ahmad I.; Pandit J.; Sultana Y.; Mishra A.K.; Hazari P.P.; Aqil M.; Optimization by design of etoposide loaded solid lipid nanoparticles for ocular delivery: Characterization, pharmacokinetic and deposition study. Mater Sci Eng C 2019,100,959-970","journal-title":"Mater Sci Eng C"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3109\/03639045.2013.795582","volume":"40","author":"Li J.","year":"2014","unstructured":"Li J.; Guo X.; Liu Z.; Okeke C.I.; Li N.; Zhao H.; Aggrey M.O.; Pan W.; Wu T.; Preparation and evaluation of charged solid lipid nanoparticles of tetrandrine for ocular drug delivery system: pharmacokinetics, cytotoxicity and cellular uptake studies. Drug Dev Ind Pharm 2014,40(7),980-987","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"117392","DOI":"10.1016\/j.saa.2019.117392","volume":"224","author":"Rapalli V.K.","year":"2020","unstructured":"Rapalli V.K.; Kaul V.; Gorantla S.; Waghule T.; Dubey S.K.; Pandey M.M.; Singhvi G.U.V.; Spectrophotometric method for characteri-zation of curcumin loaded nanostructured lipid nanocarriers in simulated conditions: Method development, in-vitro and ex-vivo applica-tions in topical delivery. Spectrochim Acta A Mol Biomol Spectrosc 2020,224,117392","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1002\/jssc.201900538","volume":"42","author":"Rapalli V.K.","year":"2019","unstructured":"Rapalli V.K.; Singhvi G.; Gorantla S.; Waghule T.; Dubey S.K.; Saha R.N.; Hasnain M.S.; Nayak A.K.; Stability indicating liquid chromatographic method for simultaneous quantification of betamethasone valerate and tazarotene in in vitro and ex vivo studies of com-plex nanoformulation. J Sep Sci 2019,42(22),3413-3420","journal-title":"J Sep Sci"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2217\/nnm.10.10","volume":"5","author":"Trivedi R.","year":"2010","unstructured":"Trivedi R.; Kompella U.B.; Nanomicellar formulations for sustained drug delivery: strategies and underlying principles. Nanomedicine 2010,5(3),485-505","journal-title":"Nanomedicine"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1080\/03639045.2017.1349787","volume":"43","author":"Li M.","year":"2017","unstructured":"Li M.; Xin M.; Guo C.; Lin G.; Wu X.; New nanomicelle curcumin formulation for ocular delivery: Improved stability, solubility, and ocular anti-inflammatory treatment. Drug Dev Ind Pharm 2017,43(11),1846-1857","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1016\/j.xphs.2016.03.006","volume":"105","author":"Alvarez-Rivera F.","year":"2016","unstructured":"Alvarez-Rivera F.; Fern\u00e1ndez-Villanueva D.; Concheiro A.; Alvarez-Lorenzo C.; \u03b1-Lipoic acid in Soluplus\u00ae Polymeric Nanomicelles for ocular treatment of diabetes-associated corneal diseases. J Pharm Sci 2016,105(9),2855-2863","journal-title":"J Pharm Sci"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jconrel.2017.01.012","volume":"248","author":"Mandal A.","year":"2017","unstructured":"Mandal A.; Bisht R.; Rupenthal I.D.; Mitra A.K.; Polymeric micelles for ocular drug delivery: From structural frameworks to recent pre-clinical studies. J Control Release 2017,248,96-116","journal-title":"J Control Release"},{"key":"ref=111","first-page":"2517","volume":"9","author":"Lou J.","year":"2014","unstructured":"Lou J.; Hu W.; Tian R.; Zhang H.; Jia Y.; Zhang J.; Zhang L.; Optimization and evaluation of a thermoresponsive ophthalmic in situ gel containing curcumin-loaded albumin nanoparticles. Int J Nanomedicine 2014,9,2517-2525","journal-title":"Int J Nanomedicine"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2017018693","volume":"34","author":"Cunha S.","year":"2017","unstructured":"Cunha S.; Amaral M.H.; Lobo J.M.S.; Silva A.C.; Lipid nanoparticles for nasal\/intranasal drug delivery. Crit Rev Ther Drug Carrier Syst 2017,34(3),257-282","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"111643","DOI":"10.1016\/j.msec.2020.111643","volume":"119","author":"da Silva J.B.","year":"2021","unstructured":"da Silva J.B.; dos Santos R.S.; da Silva M.B.; Braga G.; Cook M.T.; Bruschi M.L.; Interaction between mucoadhesive cellulose deriva-tives and Pluronic F127: Investigation on the micelle structure and mucoadhesive performance. Mater Sci Eng C 2021,119,111643","journal-title":"Mater Sci Eng C"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1208\/s12249-021-02051-5","volume":"22","author":"Mirzaeei S.","year":"2021","unstructured":"Mirzaeei S.; Taghe S.; Asare-Addo K.; Nokhodchi A.; Polyvinyl alcohol\/chitosan single-layered and polyvinyl alcohol\/chitosan\/eudragit RL100 Multi-layered electrospun nanofibers as an ocular matrix for the controlled release of ofloxacin: An in vitro and in vivo evaluation. AAPS PharmSciTech 2021,22(5),170","journal-title":"AAPS PharmSciTech"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/10837450.2022.2055063","volume":"27","author":"Osi B.","year":"2022","unstructured":"Osi B.; Khoder M.; Al-Kinani A.A.; Alany R.G.; Pharmaceutical, biomedical and ophthalmic applications of biodegradable polymers (BDPs): Literature and patent review. Pharm Dev Technol 2022,27(3),341-356","journal-title":"Pharm Dev Technol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1002\/bit.28043","volume":"119","author":"Williams L.","year":"2022","unstructured":"Williams L.; Hatton F.L.; Willcock H.; Mele E.; Electrospinning of stimuli\u2010responsive polymers for controlled drug delivery: pH\u2010 and temperature\u2010driven release. Biotechnol Bioeng 2022,119(5),1177-1188","journal-title":"Biotechnol Bioeng"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1007\/s13346-022-01155-0","volume":"12","author":"Khare P.","year":"2022","unstructured":"Khare P.; Chogale M.M.; Kakade P.; Patravale V.B.; Gellan gum-based in situ gelling ophthalmic nanosuspension of Posaconazole. Drug Deliv Transl Res 2022,12(12),2920-2935","journal-title":"Drug Deliv Transl Res"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"118286","DOI":"10.1016\/j.carbpol.2021.118286","volume":"269","author":"Marangoni J\u00fanior L.","year":"2021","unstructured":"Marangoni J\u00fanior L.; da Silva R.G.; Anjos C.A.R.; Vieira R.P.; Alves R.M.V.; Effect of low concentrations of SiO2 nanoparticles on the physical and chemical properties of sodium alginate-based films. Carbohydr Polym 2021,269,118286","journal-title":"Carbohydr Polym"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3390\/pharmaceutics13050619","volume":"13","author":"Paml\u00e9nyi K.","year":"2021","unstructured":"Paml\u00e9nyi K.; Krist\u00f3 K.; J\u00f3j\u00e1rt-Laczkovich O.; Regdon G.; Formulation and optimization of sodium alginate polymer film as a buccal mucoadhesive drug delivery system containing cetirizine dihydrochloride. Pharmaceutics 2021,13(5),619","journal-title":"Pharmaceutics"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1080\/09205063.2021.1927460","volume":"32","author":"Maddiboyina B.","year":"2021","unstructured":"Maddiboyina B.; Jhawat V.; Desu P.K.; Gandhi S.; Nakkala R.K.; Singh S.; Formulation and evaluation of thermosensitive flurbiprofen in situ nano gel for the ocular delivery. J Biomater Sci Polym Ed 2021,32(12),1584-1597","journal-title":"J Biomater Sci Polym Ed"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0378-5173(00)00359-8","volume":"199","author":"Kaur I.P.","year":"2000","unstructured":"Kaur I.P.; Singh M.; Kanwar M.; Formulation and evaluation of ophthalmic preparations of acetazolamide. Int J Pharm 2000,199(2),119-127","journal-title":"Int J Pharm"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rinphs.2015.06.001","volume":"6","author":"Makwana S.B.","year":"2016","unstructured":"Makwana S.B.; Patel V.A.; Parmar S.J.; Development and characterization of in situ gel for ophthalmic formulation containing ciprofloxa-cin hydrochloride. Results Pharma Sci 2016,6,1-6","journal-title":"Results Pharma Sci"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijpharm.2011.03.054","volume":"411","author":"Asasutjarit R.","year":"2011","unstructured":"Asasutjarit R.; Thanasanchokpibull S.; Fuongfuchat A.; Veeranondha S.; Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels. Int J Pharm 2011,411(1-2),128-135","journal-title":"Int J Pharm"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1248\/cpb.c14-00451","volume":"62","author":"Li J.","year":"2014","unstructured":"Li J.; Liu H.; Liu L.; Cai C.; Xin H.; Liu W.; Design and evaluation of a brinzolamide drug-resin in situ thermosensitive gelling system for sustained ophthalmic drug delivery. Chem Pharm Bull 2014,62(10),1000-1008","journal-title":"Chem Pharm Bull"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ijpharm.2016.04.021","volume":"506","author":"Morsi N.","year":"2016","unstructured":"Morsi N.; Ghorab D.; Refai H.; Teba H.; Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery. Int J Pharm 2016,506(1-2),57-67","journal-title":"Int J Pharm"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s13346-015-0262-y","volume":"6","author":"Ambhore N.P.","year":"2016","unstructured":"Ambhore N.P.; Dandagi P.M.; Gadad A.P.; Formulation and comparative evaluation of HPMC and water soluble chitosan-based spar-floxacin nanosuspension for ophthalmic delivery. Drug Deliv Transl Res 2016,6(1),48-56","journal-title":"Drug Deliv Transl Res"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3109\/03639041003801893","volume":"36","author":"Qian Y.","year":"2010","unstructured":"Qian Y.; Wang F.; Li R.; Zhang Q.; Xu Q.; Preparation and evaluation of in situ gelling ophthalmic drug delivery system for methazola-mide. Drug Dev Ind Pharm 2010,36(11),1340-1347","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.3109\/03639041003801885","volume":"36","author":"Ammar H.O.","year":"2010","unstructured":"Ammar H.O.; Salama H.A.; Ghorab M.; Mahmoud A.A.; Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery. Drug Dev Ind Pharm 2010,36(11),1330-1339","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijpharm.2011.03.007","volume":"410","author":"Wu H.","year":"2011","unstructured":"Wu H.; Liu Z.; Peng J.; Li L.; Li N.; Li J.; Pan H.; Design and evaluation of baicalin-containing in situ pH-triggered gelling system for sustained ophthalmic drug delivery. Int J Pharm 2011,410(1-2),31-40","journal-title":"Int J Pharm"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3797\/scipharm.1001-06","volume":"78","author":"Gupta S.","year":"2010","unstructured":"Gupta S.; Vyas S.P.; Carbopol\/chitosan based pH triggered in situ gelling system for ocular delivery of timolol maleate. Sci Pharm 2010,78(4),959-976","journal-title":"Sci Pharm"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4103\/0975-7406.94138","volume":"4","author":"Dholakia M.","year":"2012","unstructured":"Dholakia M.; Thakkar V.; Patel N.; Gandhi T.; Development and characterisation of thermo reversible mucoadhesive moxifloxacin hy-drochloride in situ ophthalmic gel. J Pharm Bioallied Sci 2012,4(Suppl. 1),42-45","journal-title":"J Pharm Bioallied Sci"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.3762\/bjoc.10.308","volume":"10","author":"Fern\u00e1ndez-Ferreiro A.","year":"2014","unstructured":"Fern\u00e1ndez-Ferreiro A.; Fern\u00e1ndez Bargiela N.; Varela M.S.; Mart\u00ednez M.G.; Pardo M.; Pi\u00f1eiro Ces A.; M\u00e9ndez J.B.; Barcia M.G.; La-mas M.J.; Otero-Espinar F.; Cyclodextrin-polysaccharide-based, in situ-gelled system for ocular antifungal delivery. Beilstein J Org Chem 2014,10,2903-2911","journal-title":"Beilstein J Org Chem"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ijpharm.2012.12.049","volume":"443","author":"Tayel S.A.","year":"2013","unstructured":"Tayel S.A.; El-Nabarawi M.A.; Tadros M.I.; Abd-Elsalam W.H.; Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: Design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits. Int J Pharm 2013,443(1-2),293-305","journal-title":"Int J Pharm"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1021\/mp200140e","volume":"8","author":"Rupenthal I.D.","year":"2011","unstructured":"Rupenthal I.D.; Alany R.G.; Green C.R.; Ion-activated in situ gelling systems for antisense oligodeoxynucleotide delivery to the ocular surface. Mol Pharm 2011,8(6),2282-2290","journal-title":"Mol Pharm"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.carbpol.2016.08.073","volume":"155","author":"Yu S.","year":"2017","unstructured":"Yu S.; Zhang X.; Tan G.; Tian L.; Liu D.; Liu Y.; Yang X.; Pan W.; A novel pH-induced thermosensitive hydrogel composed of car-boxymethyl chitosan and poloxamer cross-linked by glutaraldehyde for ophthalmic drug delivery. Carbohydr Polym 2017,155,208-217","journal-title":"Carbohydr Polym"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3109\/10611860903508788","volume":"18","author":"Gupta H.","year":"2010","unstructured":"Gupta H.; Velpandian T.; Jain S.; Ion- and pH-activated novel in situ gel system for sustained ocular drug delivery. J Drug Target 2010,18(7),499-505","journal-title":"J Drug Target"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajps.2018.04.008","volume":"14","author":"Wu Y.","year":"2019","unstructured":"Wu Y.; Liu Y.; Li X.; Kebebe D.; Zhang B.; Ren J.; Lu J.; Li J.; Du S.; Liu Z.; Research progress of in situ gelling ophthalmic drug delivery system. Asian J Pharmaceut Sci 2019,14(1),1-15","journal-title":"Asian J Pharmaceut Sci"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i1.30","volume":"26","author":"Mundada A.S.","year":"2009","unstructured":"Mundada A.S.; Avari J.G.; In situ gelling polymers in ocular drug delivery systems: A review. Crit Rev Ther Drug Carrier Syst 2009,26(1),85-118","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref=139","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/1872211309666150724101227","volume":"9","author":"Sheshala R.","year":"2015","unstructured":"Sheshala R.; Kok Y.Y.; Ng J.M.; Thakur R.R.; Dua K.; In situ gelling ophthalmic drug delivery system: An overview and its applica-tions. Recent Pat Drug Deliv Formul 2015,9(3),237-248","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/nano11010173","volume":"11","author":"Khiev D.","year":"2021","unstructured":"Khiev D.; Mohamed Z.A.; Vichare R.; Paulson R.; Bhatia S.; Mohapatra S.; Lobo G.P.; Valapala M.; Kerur N.; Passaglia C.L.; Mo-hapatra S.S.; Biswal M.R.; Emerging nano-formulations and nanomedicines applications for ocular drug delivery. Nanomaterials 2021,11(1),173","journal-title":"Nanomaterials"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.addr.2005.09.004","volume":"57","author":"Hughes P.","year":"2005","unstructured":"Hughes P.; Olejnik O.; Changlin J.; Wilson C.; Topical and systemic drug delivery to the posterior segments. Adv Drug Deliv Rev 2005,57(14),2010-2032","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijpharm.2010.06.015","volume":"396","author":"Gan L.","year":"2010","unstructured":"Gan L.; Han S.; Shen J.; Zhu J.; Zhu C.; Zhang X.; Gan Y.; Self-assembled liquid crystalline nanoparticles as a novel ophthalmic deliv-ery system for dexamethasone: Improving preocular retention and ocular bioavailability. Int J Pharm 2010,396(1-2),179-187","journal-title":"Int J Pharm"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1166\/jbn.2010.1169","volume":"6","author":"Potta S.G.","year":"2010","unstructured":"Potta S.G.; Minemi S.; Nukala R.K.; Peinado C.; Lamprou D.A.; Urquhart A.; Douroumis D.; Development of solid lipid nanoparticles for enhanced solubility of poorly soluble drugs. J Biomed Nanotechnol 2010,6(6),634-640","journal-title":"J Biomed Nanotechnol"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.nano.2009.02.003","volume":"5","author":"Ara\u00fajo J.","year":"2009","unstructured":"Ara\u00fajo J.; Gonzalez E.; Egea M.A.; Garcia M.L.; Souto E.B.; Nanomedicines for ocular NSAIDs: Safety on drug delivery. Nanomedicine 2009,5(4),394-401","journal-title":"Nanomedicine"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"12368","DOI":"10.3390\/ijms222212368","volume":"22","author":"Vaneev A.","year":"2021","unstructured":"Vaneev A.; Tikhomirova V.; Chesnokova N.; Popova E.; Beznos O.; Kost O.; Klyachko N.; Nanotechnology for topical drug delivery to the anterior segment of the eye. Int J Mol Sci 2021,22(22),12368","journal-title":"Int J Mol Sci"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"850757","DOI":"10.3389\/fchem.2022.850757","volume":"10","author":"Razavi M.S.","year":"2022","unstructured":"Razavi M.S.; Ebrahimnejad P.; Fatahi Y.; D\u2019Emanuele A.; Dinarvand R.; Recent developments of nanostructures for the ocular delivery of natural compounds. Front Chem 2022,10,850757","journal-title":"Front Chem"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","volume":"61","author":"Lai S.K.","year":"2009","unstructured":"Lai S.K.; Wang Y.Y.; Hanes J.; Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev 2009,61(2),158-171","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201820666230504115446","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/216525\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201820666230504115446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T12:19:54Z","timestamp":1700655594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/216525\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":147,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567201820666230504115446","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-11-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}